Blood:TdT通过启动FLT3-ITD复制滑移促进AML

2019-10-21 QQY MedSci原创

FLT3-ITDs (FLT3内部串联重复)是急性髓系白血病(AML)的预后驱动突变。虽然这些短重复突变发生在25%的AML患者中,但其形成的分子机制却仍不明确。了解FLT3-ITDs的起源将有助于我们进一步了解AML的起源。

FLT3-ITDs (FLT3内部串联重复)是急性髓系白血病(AML)的预后驱动突变。虽然这些短重复突变发生在25%的AML患者中,但其形成的分子机制却仍不明确。了解FLT3-ITDs的起源将有助于我们进一步了解AML的起源。

为了解析FLT3-ITDs的形成机制,研究人员分析了300个FLT3-ITDs的序列和分子解剖,包括114个在重复序列的两个重复拷贝之间有未知来源的额外的核苷酸的ITDs。

研究人员观察到了与重复滑移相一致的剖析现象,但仅1/3 FLT3-ITDs的滑移有种系微同源性(1-6 bp)参与。研究人员解释了通过神秘的微同源来解释大多数FLT3-ITDs中“缺失”微同源性的悖论:具体来说,是通过末端脱氧核苷酸转移酶(TdT)添加的非模板核苷酸(N-核苷酸)启动的。

研究人员认为,TdT介导的核苷酸添加超过了启动所需的量,从而在复制连接处产生N-区,可解释在这个位置观察到的额外核苷酸。FLT3-ITD N-区的G/C含量(66.9%)、二核苷酸组成和长度特征均与TdT合成一致。高TdT的AML的FLT3-ITDs发生率随之增加。

本研究结果揭示了淋巴样酶TdT在启动FLT3-ITDs中的作用。虽然TdT的生理作用是在IG/TCR基因V(D)J重组过程中通过增加N-核苷酸来增加抗原多样性,但本研究结果提示TdT活性异常对AML的发生有重要作用。

原始出处:

Julian Borrow, et al.Terminal Deoxynucleotidyl Transferase Promotes Acute Myeloid Leukemia By Priming FLT3-ITD Replication Slippage.Blood.2019001238. https://doi.org/10.1182/blood.2019001238

本文系梅斯医学(MedSci)原创编译,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2058245, encodeId=4e3f20582450f, content=<a href='/topic/show?id=9e921e241fe' target=_blank style='color:#2F92EE;'>#TdT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17241, encryptionId=9e921e241fe, topicName=TdT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce68183, createdName=xiongke010, createdTime=Sat Jul 18 13:42:00 CST 2020, time=2020-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1527235, encodeId=604f152e23523, content=<a href='/topic/show?id=cadee515ca' target=_blank style='color:#2F92EE;'>#FLT3-ITD#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7515, encryptionId=cadee515ca, topicName=FLT3-ITD)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db0c11820220, createdName=kord1986, createdTime=Wed Oct 23 14:42:00 CST 2019, time=2019-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1538890, encodeId=f9fb1538890c2, content=<a href='/topic/show?id=5f04e51467' target=_blank style='color:#2F92EE;'>#FLT3#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7514, encryptionId=5f04e51467, topicName=FLT3)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=57a713069145, createdName=fengyi816, createdTime=Wed Oct 23 14:42:00 CST 2019, time=2019-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=374200, encodeId=12be3e42000d, content=学习学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRkia1DP5MpwEgtXo1XhXA11xD6MWKxunAZFXKSNic0fWHUQx83oNHPlRMxxIctM83QKeCLkJpMibibiaC/0, createdBy=7e581734408, createdName=深海的鱼, createdTime=Tue Oct 22 02:06:16 CST 2019, time=2019-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=374198, encodeId=73bb3e4198fd, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Tue Oct 22 00:21:48 CST 2019, time=2019-10-22, status=1, ipAttribution=)]
    2020-07-18 xiongke010
  2. [GetPortalCommentsPageByObjectIdResponse(id=2058245, encodeId=4e3f20582450f, content=<a href='/topic/show?id=9e921e241fe' target=_blank style='color:#2F92EE;'>#TdT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17241, encryptionId=9e921e241fe, topicName=TdT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce68183, createdName=xiongke010, createdTime=Sat Jul 18 13:42:00 CST 2020, time=2020-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1527235, encodeId=604f152e23523, content=<a href='/topic/show?id=cadee515ca' target=_blank style='color:#2F92EE;'>#FLT3-ITD#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7515, encryptionId=cadee515ca, topicName=FLT3-ITD)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db0c11820220, createdName=kord1986, createdTime=Wed Oct 23 14:42:00 CST 2019, time=2019-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1538890, encodeId=f9fb1538890c2, content=<a href='/topic/show?id=5f04e51467' target=_blank style='color:#2F92EE;'>#FLT3#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7514, encryptionId=5f04e51467, topicName=FLT3)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=57a713069145, createdName=fengyi816, createdTime=Wed Oct 23 14:42:00 CST 2019, time=2019-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=374200, encodeId=12be3e42000d, content=学习学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRkia1DP5MpwEgtXo1XhXA11xD6MWKxunAZFXKSNic0fWHUQx83oNHPlRMxxIctM83QKeCLkJpMibibiaC/0, createdBy=7e581734408, createdName=深海的鱼, createdTime=Tue Oct 22 02:06:16 CST 2019, time=2019-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=374198, encodeId=73bb3e4198fd, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Tue Oct 22 00:21:48 CST 2019, time=2019-10-22, status=1, ipAttribution=)]
    2019-10-23 kord1986
  3. [GetPortalCommentsPageByObjectIdResponse(id=2058245, encodeId=4e3f20582450f, content=<a href='/topic/show?id=9e921e241fe' target=_blank style='color:#2F92EE;'>#TdT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17241, encryptionId=9e921e241fe, topicName=TdT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce68183, createdName=xiongke010, createdTime=Sat Jul 18 13:42:00 CST 2020, time=2020-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1527235, encodeId=604f152e23523, content=<a href='/topic/show?id=cadee515ca' target=_blank style='color:#2F92EE;'>#FLT3-ITD#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7515, encryptionId=cadee515ca, topicName=FLT3-ITD)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db0c11820220, createdName=kord1986, createdTime=Wed Oct 23 14:42:00 CST 2019, time=2019-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1538890, encodeId=f9fb1538890c2, content=<a href='/topic/show?id=5f04e51467' target=_blank style='color:#2F92EE;'>#FLT3#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7514, encryptionId=5f04e51467, topicName=FLT3)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=57a713069145, createdName=fengyi816, createdTime=Wed Oct 23 14:42:00 CST 2019, time=2019-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=374200, encodeId=12be3e42000d, content=学习学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRkia1DP5MpwEgtXo1XhXA11xD6MWKxunAZFXKSNic0fWHUQx83oNHPlRMxxIctM83QKeCLkJpMibibiaC/0, createdBy=7e581734408, createdName=深海的鱼, createdTime=Tue Oct 22 02:06:16 CST 2019, time=2019-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=374198, encodeId=73bb3e4198fd, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Tue Oct 22 00:21:48 CST 2019, time=2019-10-22, status=1, ipAttribution=)]
    2019-10-23 fengyi816
  4. [GetPortalCommentsPageByObjectIdResponse(id=2058245, encodeId=4e3f20582450f, content=<a href='/topic/show?id=9e921e241fe' target=_blank style='color:#2F92EE;'>#TdT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17241, encryptionId=9e921e241fe, topicName=TdT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce68183, createdName=xiongke010, createdTime=Sat Jul 18 13:42:00 CST 2020, time=2020-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1527235, encodeId=604f152e23523, content=<a href='/topic/show?id=cadee515ca' target=_blank style='color:#2F92EE;'>#FLT3-ITD#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7515, encryptionId=cadee515ca, topicName=FLT3-ITD)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db0c11820220, createdName=kord1986, createdTime=Wed Oct 23 14:42:00 CST 2019, time=2019-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1538890, encodeId=f9fb1538890c2, content=<a href='/topic/show?id=5f04e51467' target=_blank style='color:#2F92EE;'>#FLT3#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7514, encryptionId=5f04e51467, topicName=FLT3)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=57a713069145, createdName=fengyi816, createdTime=Wed Oct 23 14:42:00 CST 2019, time=2019-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=374200, encodeId=12be3e42000d, content=学习学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRkia1DP5MpwEgtXo1XhXA11xD6MWKxunAZFXKSNic0fWHUQx83oNHPlRMxxIctM83QKeCLkJpMibibiaC/0, createdBy=7e581734408, createdName=深海的鱼, createdTime=Tue Oct 22 02:06:16 CST 2019, time=2019-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=374198, encodeId=73bb3e4198fd, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Tue Oct 22 00:21:48 CST 2019, time=2019-10-22, status=1, ipAttribution=)]
    2019-10-22 深海的鱼

    学习学习学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2058245, encodeId=4e3f20582450f, content=<a href='/topic/show?id=9e921e241fe' target=_blank style='color:#2F92EE;'>#TdT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17241, encryptionId=9e921e241fe, topicName=TdT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce68183, createdName=xiongke010, createdTime=Sat Jul 18 13:42:00 CST 2020, time=2020-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1527235, encodeId=604f152e23523, content=<a href='/topic/show?id=cadee515ca' target=_blank style='color:#2F92EE;'>#FLT3-ITD#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7515, encryptionId=cadee515ca, topicName=FLT3-ITD)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db0c11820220, createdName=kord1986, createdTime=Wed Oct 23 14:42:00 CST 2019, time=2019-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1538890, encodeId=f9fb1538890c2, content=<a href='/topic/show?id=5f04e51467' target=_blank style='color:#2F92EE;'>#FLT3#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7514, encryptionId=5f04e51467, topicName=FLT3)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=57a713069145, createdName=fengyi816, createdTime=Wed Oct 23 14:42:00 CST 2019, time=2019-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=374200, encodeId=12be3e42000d, content=学习学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRkia1DP5MpwEgtXo1XhXA11xD6MWKxunAZFXKSNic0fWHUQx83oNHPlRMxxIctM83QKeCLkJpMibibiaC/0, createdBy=7e581734408, createdName=深海的鱼, createdTime=Tue Oct 22 02:06:16 CST 2019, time=2019-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=374198, encodeId=73bb3e4198fd, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Tue Oct 22 00:21:48 CST 2019, time=2019-10-22, status=1, ipAttribution=)]
    2019-10-22 147612bem32暂无昵称

    学习了

    0

相关资讯

Blood:AML的核蛋白(NPM1)突变

核蛋白(NPM1)是急性髓系白血病(AML)最常见的突变基因。2016年WHO分类将携带NPM1突变的AML划分为一个单独的实体,该类AML的预后相对较好。NPM1突变主要是在终端外显子中通过未知机制重复或插入了4bp。